🟢 Tenaya Therapeutics is trading 5% up today ahead of its Q2 earnings report

Tenaya Therapeutics is trading 5% up at $0.76 as investors position ahead of its Q2 2026 earnings report.

• The company is scheduled to release its quarterly financial results on August 5, 2026.
• Shares are also benefiting from a broadly risk-on market backdrop, with major U.S. indices gaining over 1%.
• The positive macro environment is providing a significant tailwind for small-cap biotech sentiment.